Interrogating mechanisms of liver fibrosis with omics
- PMID: 34903888
- DOI: 10.1038/s41575-021-00567-6
Interrogating mechanisms of liver fibrosis with omics
References
-
- Arthur, M. J. P. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122, 1525–1528 (2002). - DOI
-
- Fallowfield, J. A., Jimenez-Ramos, M. & Robertson, A. Emerging synthetic drugs for the treatment of liver cirrhosis. Expert Opin. Emerg. Drugs 26, 149–163 (2021). - DOI
-
- Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512–518 (2019). - DOI
-
- Loft, A. et al. Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. Cell Metab. 33, 1685–1700 (2021). - DOI
-
- Higashi, T., Friedman, S. L. & Hoshida, Y. Hepatic stellate cells as key target in liver fibrosis. Adv. Drug Deliv. Rev. 121, 27–42 (2017). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical